{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:23:22Z","timestamp":1761920602094,"version":"build-2065373602"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,29]],"date-time":"2020-12-29T00:00:00Z","timestamp":1609200000000},"content-version":"vor","delay-in-days":728,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2019]]},"DOI":"10.1136\/esmoopen-2019-000542","type":"journal-article","created":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T13:35:10Z","timestamp":1563284110000},"page":"e000542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"S2","title":["How I treat squamous ENT cancer"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7944-7467","authenticated-orcid":false,"given":"Marco Carlo","family":"Merlano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nerina","family":"Denaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danilo","family":"Galizia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ornella","family":"Garrone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/esmoopen-2019-000542_bb0010","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.oraloncology.2016.06.002","article-title":"Evaluation of the benefit and use of multidisciplinary teams in the treatment of head and neck cancer","volume":"59","author":"Licitra","year":"2016","journal-title":"Oral Oncol"},{"key":"10.1136\/esmoopen-2019-000542_bb0015","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients","volume":"92","author":"Pignon","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1136\/esmoopen-2019-000542_bb0020","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1200\/JCO.2014.55.3925","article-title":"Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the radiation therapy oncology group 0129 trial: long-term report of efficacy and toxicity","volume":"32","author":"Nguyen-Tan","year":"2014","journal-title":"JCO"},{"key":"10.1136\/esmoopen-2019-000542_bb0025","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1200\/JCO.2017.74.9457","article-title":"Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial","volume":"36","author":"Noronha","year":"2018","journal-title":"JCO"},{"key":"10.1136\/esmoopen-2019-000542_bb0030","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.oraloncology.2012.05.001","article-title":"Impact of age on acute toxicity induced by bio- or chemo-radiotherapy in patients with head and neck cancer","volume":"48","author":"Merlano","year":"2012","journal-title":"Oral Oncology"},{"key":"10.1136\/esmoopen-2019-000542_bb0035","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2018-000346","article-title":"High incidence of cetuximab-related infusion reactions in head and neck patients","volume":"3","author":"Palomar Coloma","year":"2018","journal-title":"ESMO Open"},{"key":"10.1136\/esmoopen-2019-000542_bb0040","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ijrobp.2007.09.058","article-title":"Adjuvant radiotherapy and survival for patients with node-positive head and neck cancer: an analysis by primary site and nodal stage","volume":"71","author":"Kao","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/esmoopen-2019-000542_bb0045","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/hed.20465","article-title":"Postoperative chemoradiotherapy for advanced squamous cell carcinoma of the head and neck: A systematic review with meta-analysis","volume":"29","author":"Winquist","year":"2007","journal-title":"Head Neck"},{"key":"10.1136\/esmoopen-2019-000542_bb0050","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.radonc.2013.08.016","article-title":"A systematic review of current and emerging approaches in the field of larynx preservation","volume":"110","author":"Denaro","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1136\/esmoopen-2019-000542_bb0055","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1200\/JCO.2012.43.6097","article-title":"Long-Term Results of RTOG 91-11: A Comparison of Three Nonsurgical Treatment Strategies to Preserve the Larynx in Patients With Locally Advanced Larynx Cancer","volume":"31","author":"Forastiere","year":"2013","journal-title":"JCO"},{"key":"10.1136\/esmoopen-2019-000542_bb0060","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ejca.2016.06.024","article-title":"Long-term update of the 24954 EORTC phase III trial on larynx preservation","volume":"65","author":"Henriques De Figueiredo","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1136\/esmoopen-2019-000542_bb0065","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1093\/jnci\/djp007","article-title":"Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation","volume":"101","author":"Pointreau","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1136\/esmoopen-2019-000542_bb0070","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(18)32779-X","article-title":"Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial","volume":"393","author":"Gillison","year":"2019","journal-title":"The Lancet"},{"key":"10.1136\/esmoopen-2019-000542_bb0075","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJMoa0802656","article-title":"Platinum-based chemotherapy plus cetuximab in head and neck cancer","volume":"359","author":"Vermorken","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1136\/esmoopen-2019-000542_bb0080","doi-asserted-by":"crossref","first-page":"217","DOI":"10.21053\/ceo.2018.00150","article-title":"Immunotherapy in Head and Neck Squamous Cell Cancer","volume":"11","author":"Denaro","year":"2018","journal-title":"Clin Exp Otorhinolaryngol"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702920326168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702920326168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/esmoopen-2019-000542","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:23:20Z","timestamp":1761855800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2059702920326168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":15,"alternative-id":["S2059702920326168"],"URL":"https:\/\/doi.org\/10.1136\/esmoopen-2019-000542","relation":{},"ISSN":["2059-7029"],"issn-type":[{"type":"print","value":"2059-7029"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How I treat squamous ENT cancer","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/esmoopen-2019-000542","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 THE AUTHORS. Published by Elsevier Limited on behalf of European Society for Medical Oncology; Originally published by BMJ.","name":"copyright","label":"Copyright"}],"article-number":"e000542"}}